Peter R. Martin
Vanderbilt University
166 Papers
1.9K Citations
Peter R. Martin is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Buprenorphine & Medicine. The author has an hindex of 44, co-authored 150 publications. Previous affiliations of Peter R. Martin include University of California, Irvine & Harvard University.
Chat about Author
Papers
Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure
Hendrée E. Jones,Karol Kaltenbach,Sarah H. Heil,Susan M. Stine,Mara G. Coyle,Amelia M. Arria,Kevin E. O'Grady,Peter Selby,Peter R. Martin,Gabriele Fischer +9 more
TL;DR: A comparison of the 131 neonates whose mothers were followed to the end of pregnancy according to treatment group showed that the former group required significantly less morphine, which is consistent with the use of buprenorphine as an acceptable treatment for opioid dependence in pregnant women.
Effect of roasting on the formation of chlorogenic acid lactones in coffee.
TL;DR: The levels of lactones in roasted coffee do not reflect the levels of precursors in green coffee, suggesting that roasting causes isomerization of chlorogenic acids prior to the formation of lactone levels.
549
•Journal Article
The role of thiamine deficiency in alcoholic brain disease.
TL;DR: A deficiency in the essential nutrient thiamine resulting from chronic alcohol consumption is one factor underlying alcohol-induced brain damage, including Wernicke-Korsakoff syndrome, which is found predominantly in alcoholics.
Molecular mechanisms of thiamine utilization.
TL;DR: Substantial efforts are being made to understand the genetic and biochemical determinants of inter-individual differences in susceptibility to development of thiamine deficiency-related disorders and of the differential vulnerabilities of tissues and cell types to thiamines deficiency.
327
Prescription Opioid Epidemic and Infant Outcomes
Stephen W. Patrick,Judith A. Dudley,Peter R. Martin,Frank E. Harrell,Michael D. Warren,Katherine E Hartmann,E. Wesley Ely,Carlos G. Grijalva,William O. Cooper +8 more
TL;DR: Antenatal cumulative prescription opioid exposure, opioid type, tobacco use, and selective serotonin reuptake inhibitor use increase the risk of neonatal abstinence syndrome.